BioTime (BTX) Signs Definitive Agreement With Geron Corporation (GERN) Regarding Stem Cell Assets
1/7/2013 10:09:04 AM
More...
|
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs
12/4/2012 7:37:22 AM
More...
|
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program
10/25/2012 9:07:17 AM
More...
|
BioTime (BTX) Issues Open Letter to Shareholders of Geron Corporation (GERN)
10/18/2012 9:29:16 AM
More...
|
Geron Corporation (GERN) Ends Breast Cancer Study of Imetelstat
9/10/2012 7:32:38 AM
More...
|
Geron Corporation (GERN) Gains on Report Touting Experimental Cancer Drugs
8/20/2012 7:33:39 AM
More...
|
Geron Corporation (GERN) Hires Stifel to Sell Stem Cell Assets, CEO Says
1/12/2012 8:00:26 AM
More...
|
Geron Corporation (GERN) Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer
12/12/2011 6:38:36 AM
More...
|
Geron Corporation (GERN): A Tribute to Alex Barkas
11/23/2011 10:06:47 AM
More...
|
Geron Corporation (GERN) to Focus on Its Novel Cancer Programs
11/15/2011 8:08:35 AM
More...
|
|